126 results on '"A NICOSIA"'
Search Results
2. Prostate volume variation during 1.5T MR-guided adaptive stereotactic body radiotherapy (SBRT) and correlation with treatment toxicity
3. Radiation therapy for stage IIA/IIB seminomas: Back to the future?
4. 3157: Profiling PCa pts with BCR in the era of early imaging detection: a ML nomogram
5. 1721: Process mining for care path analysis in PCa patients undergoing salvage radiotherapy: an AIRO study
6. 1281: Repeated monosicentric-SRS for brain metastases and dosimetric analysis of recurrence pattern
7. 881: Prostate volume change during 1.5T MR-guided adaptive SBRT and correlation with treatment toxicity
8. PO-1485 1.5T MR-guided daily adaptive radiotherapy: preliminary clinical report of the first 5000 fractions
9. PO-1491 Profiling PCa patients with BCR in the era of early imaging detection: an AIRO-URO group study
10. PO-1601 Stereotactic body radiotherapy (SBRT) with or without dose boost in spinal oligometastatic patients
11. PO-1494 Process mining in PCa Salvage RT patients care path: an AIRO-URO group preliminary analysis
12. PO-1486 Feasibility and tolerability of MR-guided adaptive RT on prostatic bed:mono-institutional experience
13. PD-0250 Therapeutic use of Linac-based SRS in malignant spasticity: early results from a prospective trial
14. PO-1452 Stereotactic ablative radiotherapy in patients with refractory ventricular tachyarrhythmia
15. PO-1407 Postoperative hypofractionated RT: toxicity and efficacy in a series of 304 prostate adenocarcinoma
16. OC-0602 A pREDictive model of polymetastatic disease on oligometastatic colorectal cancer: the RED LaIT-SABR
17. PD-0086 PSMA-PET guided stereotactic body radiotherapy for bone oligorecurrent prostate cancer
18. PO-1463 SBRT for over 80years oligometastatic patients: report of feasibility and clinical outcomes
19. PO-1353 SBRT for gynecological oligometastases: mono-institutional report of toxicity and clinical outcomes
20. PO-1188 Stereotactic body RT (SBRT) and concomitant systemic therapy in oligoprogressive breast cancer
21. PD-0574 1.5T MR-guided RT versus linac-based VMAT SBRT in localized prostate cancer: a toxicity comparison
22. PD-0575 Toxicity and QoL report of 1.5T MR-guided SBRT for prostate cancer in the first 100 patients
23. Reply to: Stereotactic radiotherapy needs more evidence before it can be used routinely to treat metastases: A comment on the paper by Nicosia et al
24. A novel treatment for malignant spasticity: The therapeutic use of stereotactic radiosurgery (SRS)
25. 3062: Salvage Radiotherapy after Failure of Primary Focal Therapy for prostate cancer:A Systematic Review
26. 2508: Prostate SBRT delivered with 1.5T MR-linac or Cyberknife: a propensity score matching analysis
27. 2200: Neoadjuvant radiochemotherapy in locally advanced rectal cancer with or without radiation dose boost
28. 1083: Oligometastatic prostate cancer: different pattern of relapse between pelvic and para-aortic disease
29. A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study
30. PO-1463 SBRT for over 80years oligometastatic patients: report of feasibility and clinical outcomes
31. OC-0602 A pREDictive model of polymetastatic disease on oligometastatic colorectal cancer: the RED LaIT-SABR
32. PD-0575 Toxicity and QoL report of 1.5T MR-guided SBRT for prostate cancer in the first 100 patients
33. PD-0250 Therapeutic use of Linac-based SRS in malignant spasticity: early results from a prospective trial
34. PO-1452 Stereotactic ablative radiotherapy in patients with refractory ventricular tachyarrhythmia
35. Reply to: Stereotactic radiotherapy needs more evidence before it can be used routinely to treat metastases: A comment on the paper by Nicosia et al
36. PO-1353 Postoperative hypofractionated RT for prostate adenocarcinoma: results from a large series
37. PH-0112 Multicenter large retrospectIve database on SBRT for colorectal lung metastases: the LaIT-SABR study
38. PO-1439 Clinical results of SBRT for spinal metastases using dedicated contouring/planning system
39. PO-1376 Preliminary mono-institutional report of prostate/prostate bed SBRT re-irradiation
40. PD-0804 Therapeutic use of Linac-based SRS in the treatment of malignant spasticity
41. PO-1499 1.5T MR-guided daily adaptive radiotherapy: preliminary clinical report of the first 2000 fractions.
42. PD-0849 Concomitant Nivolumab and RT in metastatic kidney cancer. Benefit of ablative vs palliative approach
43. PO-1388 1.5 T MR-guided SBRT for oligorecurrent prostate cancer: preliminary report of feasibility and PROMs
44. PD-0863 Preliminary dosimetric report of 1.5-T MR-guided daily-adaptive SBRT for lymph-nodal oligometastases
45. PO-1153 Preliminary mono-institutional report of stereotactic body radiotherapy for lung oligometastases
46. PO-1512 Daily adaptive MR-guided SBRT for oligometastatic lymph-nodes:feasibility and preliminary experience
47. PO-1188 Stereotactic body RT (SBRT) and concomitant systemic therapy in oligoprogressive breast cancer
48. PO-1353 SBRT for gynecological oligometastases: mono-institutional report of toxicity and clinical outcomes
49. PO-1407 Postoperative hypofractionated RT: toxicity and efficacy in a series of 304 prostate adenocarcinoma
50. PD-0574 1.5T MR-guided RT versus linac-based VMAT SBRT in localized prostate cancer: a toxicity comparison
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.